UNSPSC 51261802: Efaroxan

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51261802

Definition

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G00490L21H, chemically known as (+-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline but generally known as efaroxan, which bears US NIH Compound Identifier 72016. European Medicines Agency schedules Efaroxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06462MIG.

Read the full definition

The term EFAROXAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). EFAROXAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule efaroxan under HS 29349990 and SITC 51579. As of Q4 2014, EFAROXAN remains the US FDA Preferred Term for this commodity. Efaroxan bears US NLM identifiers UMLS ID C0058957 and NCI Concept Code C72923. SMILES: O1C(CC2C1CCCC2)(CC)C1=NCCN1.

About UNSPSC 51261802

UNSPSC 51261802 Efaroxan, a Commodity code, nominally identifies pharmaceutical products, but the recent solicitation activity under this code shows state and local governments procuring naloxone and drug deactivation systems for community health and emergency response. Naloxone — an opioid antagonist — and associated safe drug disposal or deactivation equipment address public health crises, overdose response, and controlled substance management. State and local health departments, counties, and special-purpose health authorities are the primary issuing bodies under this code. The work typically involves competitive supply agreements with quarterly or regular deliveries, fixed unit pricing, compliance requirements including drug-free workplace certification and E-Verify, and standard insurance and liability provisions.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2023, at 2:00 pm. The contract term runs two years with an optional one-year renewal; quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The procurement, potentially funded through FEMA, requires vendors to submit bids electronically, provide unit costs for each line item, and comply with federal environmental regulations including the Clean Air Act and Federal Water Pollution Control Act, alongside a three-month probationary termination clause. The source provides no information on other recent opportunities, issuing bodies, or geographic spread beyond Seminole County, Florida.

Quick answers

What is UNSPSC 51261802?

UNSPSC 51261802 is Efaroxan, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51261802?

UNSPSC 51261802 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51261802

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code